Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Multiple Myeloma × Immunotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Brain Neoplasms 1

Interventions

Dexamethasone 234 Lenalidomide 132 Bortezomib 131 Cyclophosphamide 100 Melphalan 97 Calcium Dobesilate 91 fludarabine phosphate 55 carfilzomib 48 Filgrastim 47 Peripheral Blood Stem Cell Transplantation 46 Whole-Body Irradiation 45 Granulocyte Colony-Stimulating Factor 45 pomalidomide 41 Mycophenolic Acid 41 ixazomib 38 fludarabine 37 daratumumab 35 Thalidomide 33 Tacrolimus 32 Busulfan 32 Cyclosporine 26 dexamethasone acetate 25 Stem Cell Transplantation 24 Antilymphocyte Serum 22 dexamethasone 21-phosphate 20 auricularum 19 Prednisone 17 plerixafor 16 belantamab mafodotin 16 Bendamustine Hydrochloride 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03634800 2021-08-05

RISE-M

Weill Medical College of Cornell University

Phase 2 Terminated

6 enrolled 11 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡